Tectonic Therapeutic, Inc.
TECX
$32.80
-$0.51-1.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.27% | -3.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.71% | -1.98% | |||
| Operating Income | 1.71% | 1.98% | |||
| Income Before Tax | 0.33% | -0.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.00% | 4.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.00% | 4.75% | |||
| EBIT | 1.71% | 1.98% | |||
| EBITDA | 1.69% | 2.02% | |||
| EPS Basic | -0.97% | 4.92% | |||
| Normalized Basic EPS | 0.36% | 0.03% | |||
| EPS Diluted | -0.97% | 4.92% | |||
| Normalized Diluted EPS | 0.36% | 0.03% | |||
| Average Basic Shares Outstanding | 0.03% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||